<DOC>
	<DOCNO>NCT01945736</DOCNO>
	<brief_summary>The purpose study learn study drug , methadone , prescribe infant 's child 's physician part standard medical care , process child young adult . While drug use extensively infants child , extensively studied population . Physicians much information long take methadone remove blood circulation pass body . Physicians need information guide much often give methadone children/young adult ensure get maximum effect minimum amount drug . During research study , study team collect information drug process infant child .</brief_summary>
	<brief_title>Pharmacokinetics Multiple Dose Methadone Children Treated Opiate Withdrawal</brief_title>
	<detailed_description>A total approximately 24 36 infant child participate study . This study do five medical center United States . Treatment prescribe infant child 's doctor study team . Participants divide 3 group base age , age 3 month 2 year , age 2 6 year , age 6 18 year . There approximately 8 12 participant enrol group . Additionally , least 6 overweight obese participant age 2-18 year include study . Information collect subject 's routine medical care include : - Participant gender , date birth , race ethnicity - Pertinent medical history - Laboratory result ( blood count chemistry ) routine test order infant child 's regular doctor - Medications interest child give within 72 hour prior first dose methadone administer consent - Time dose methadone administer child 14 day prior enrollment Study specific information collect include : - Blood sample collection measure level methadone - Baseline WAT-1 score ( sedation withdrawal assessment infant child use ass symptom child/infant may experience opioid drug discontinue ) . The duration study 10 day , comprise maximum 5 day treatment period 5 day observation period .</detailed_description>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>&gt; 90 day &lt; 18 year age time first dose study drug Receiving enteral methadone standard care Signed inform consent/HIPAA document parent/legal guardian assent ( applicable ) Previous participation study Subject receive ECLS ( Extracorporeal Life Support ) &lt; 36 week gestational age birth child &lt; 1 year age time enrollment Any condition chronic illness opinion Principal Investigator make participation unadvised unsafe</criteria>
	<gender>All</gender>
	<minimum_age>91 Days</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Opiate withdrawal child</keyword>
</DOC>